Diversa and Celera Sequence Streptomyces Diversa Genome | GenomeWeb

NEW YORK, Feb 21 – Celera and Diversa said Wednesday they have sequenced the genome of Streptomyces diversa , a proprietary strain of Streptomyces bacteria that belongs to the group of microorganisms that produce most antibiotics.

The companies began sequencing this genome under a multi-year, cross-royalty agreement announced in December 2000, in which the two will collaborate to sequence the genomes of different microorganisms in Diversa’s Pathway Llbraries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.